Detection and genotyping of high-risk HPV and evaluation of anti-oxidant status in cervical carcinoma patients in Tamil Nadu state, India - A case control study

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2689-2695

  Nirmala, J Grace ^a   Narendhirakannan, R T ^a  

^a KARUNYA UNIVERSITY   (India)

Author keywords

Antioxidants; Cervical cancer; Free radicals; HPV genotyping; Human papillomavirus; India

Indexed keywords

EID: 84858249103     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Baker H, Frank O, Angelis DB, et al (1980). Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Int, 21, 531-6.
2. Baskar AA, Manoharan S, Manivasagam T, et al (2004). Temporal patterns of lipid peroxidation product formation and antioxidants activity in oral cancer patients. Cell Mol Biol Lett, 9, 665-73.
3. Bosch FX, de Sanjose S (2003). Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr, 3-13.
4. Bosch FX, Manos MM, Munoz N, et al (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst, 87, 796-802.
5. Chan PK, Chan DP, To KF, et al (2001). Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol, 54, 401-3.
6. Das BC, Hussain S, Nasare V, et al (2008). Prospects and prejudices of human papillomavirus vaccines in India. Vaccine, 26, 2669-79.
7. Diplock AT (1991). Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr, 53, S189-93.
8. Diplock AT, Rice-Evans CA, Burdon RH (1994). Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention? Cancer Res, 54, S1952-6.
9. Dodge JT, Mitchell C, Hanahan DJ (1963). The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys, 100, 119-30.
10. Donnan SK (1950). The thiobarbituric acid test applied to tissues from rats treated in various ways. J Biol Chem, 182, 415-9.
11. Eastwood MA (1999). Interaction of dietary antioxidants in vivo: how fruit and vegetables prevent disease? QJM, 92, 527-30.
12. Ellman GL (1959). Tissue sulfhydryl groups. Arch Biochem Biophys, 82, 70-7.
13. Eslami G, Golshani M, Rakhshan M, et al (2008). PCR detection and high risk typing of human papillomavirus DNA in cervical cancer in Iranian women. Cancer Therapy, 6, 361-6.
14. Fernandes JV, Meissner RV, Carvalho MG, et al (2010). Prevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil. BMC Res Notes, 3, 96.
15. Gokul S, Patil VS, Jailkhani R, et al (2010). Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis, 16, 29-33.
16. Grace VM, Shalini JV, Lekha TT, et al (2003). Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 91, 51-8.
17. Habig WH, Pabst MJ, Jakoby WB (1974). Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem, 249, 7130-9.
18. Halliwell B (1996). Antioxidants in human health and disease. Annu Rev Nutr, 16, 33-50.
19. Hendrix SL (2008). Assessing human papillomavirus vaccine efficacy and safety. J Am Osteopath Assoc, 108, S8-12.
20. Higgins GD, Davy M, Roder D, et al (1991). Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet, 338, 910-3.
21. Keegan L, Keegan G (2004). Cervical cancer and antioxidants. Alternative Ther Wom Health, 6, 57-64.
22. Khan S, Jaffer NN, Khan MN, et al (2007). Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. Int J Infect Dis, 11, 313-7.
23. Kling M, Zeichner JA (2010). The role of the human papillomavirus (HPV) vaccine in developing countries. Int J Dermatol, 49, 377-9.
24. Maeda H, Akaike T (1998). Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc), 63, 854-65.
25. Manju V, Kalaivani Sailaja J, Nalini N (2002). Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. Clin Biochem, 35, 621-5.
26. Mates JM, Perez-Gomez C, Nunez de Castro I (1999). Antioxidant enzymes and human diseases. Clin Biochem, 32, 595-603.
27. McCord JM (2000). The evolution of free radicals and oxidative stress. Am J Med, 108, 652-9.
28. Menegazzi P, Barzon L, Palu G, et al (2009). Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of Italy. Infect Dis Obstet Gynecol, 2009, 198425.
29. Mitrani-Rosenbaum S, Tsvieli R, Tur-Kaspa R (1989). Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol, 70, 2227-32.
30. Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95, 351-8.
31. Otamiri T, Sjodahl R (1989). Increased lipid peroxidation in malignant tissues of patients with colorectal cancer. Cancer, 64, 422-5.
32. Paavonen J, Jenkins D, Bosch FX, et al (2007). Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet, 369, 2161-70.
33. Paglia DE, Valentine WN (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med, 70, 158-69.
34. Pal SK, Mittal B (2004). Improving cancer care in India: prospects and challenges. Asian Pac J Cancer Prev, 5, 226-8.
35. Pillai MR, Hariharan R, Babu JM, et al (2009). Molecular variants of HPV-16 associated with cervical cancer in Indian population. Int J Cancer, 125, 91-103.
36. Punnonen R, Kudo R, Punnonen K, et al (1993). Activities of antioxidant enzymes and lipid peroxidation in endometrial cancer. Eur J Cancer, 29A, 266-9.
37. Quist EE (1980). Regulation of erythrocyte membrane shape by Ca2+. Biochem Biophys Res Commun, 92, 631-7.
38. Saiki RK, Gelfand DH, Stoffel S, et al (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487-91.
39. Samir M, el Kholy NM (1999). Thiobarbituric acid reactive substances in patients with laryngeal cancer. Clin Otolaryngol Allied Sci, 24, 232-4.
40. Sankaranarayanan R, Nene BM, Dinshaw K, et al (2003). Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica Mex, 45, S399-407.
41. Singh N (2005). HPV and Cervical Cancer - Prospects for prevention through vaccination. Indian J Med Paediatr Oncol, 26, 20-3.
42. Sinha AK (1972). Colorimetric assay of catalase. Anal Biochem, 47, 389-94.
43. Sowjanya AP, Jain M, Poli UR, et al (2005). Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis, 5, 116.
44. Sun Y, Oberley LW, Li Y (1988). A simple method for clinical assay of superoxide dismutase. Clin Chem, 34, 497-500.
45. Tietz NW (1986). In: Text book of clinical chemistry. Edited by NW Tietz, Saunders, W.B. Publ. Co., Philadelphia, London, Toronto; 960-962.
46. Valko M, Rhodes CJ, Moncol J, et al (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 160, 1-40.
47. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
48. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in India. Summary Report 2010.
49. Williams VM, Filippova M, Soto U, et al (2011). HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol, 6, 45-57.
50. Wu D, Cai L, Huang M, et al (2010). Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province, PR China. Eur J Obstet Gynecol Reprod Biol, 151, 86-90.